Pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that it enclosed the presentation on the financials and performance of the Company for the quarter ended June 30, 2023. The above-mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com. The Board Meeting commenced at 11:45 am and concluded at 01:50 pm.
The above information is a part of company’s filings submitted to BSE.
